Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Positivity of ExoU Gene of Type III Secretion System and Fluoroquinolone Resistance of Psedomonas aeruginosa from Sputum of Nosocomial Pneumonia Patients in Sanglah Hospital, Bali

Folia Medica Indonesiana · Vol. 54 No. 2 (2018) · hlm. 129–129

DOI
10.20473/fmi.v54i2.8863
ISSN
2355-8393, 2599-056X
Terbit
2018-07-05
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Pseudomonas aeruginosa is one of the Gram-negative rods bacteria that frequently cause nosocomial pneumonia. One of the main virulent effector proteins on Type III secretion system (TTSS) of P. aeruginosa is Exoenzyme U ( ExoU). ExoU works as a phospholipase A2 activity and exhibits lung tissue injury effect in pneumonia. As an antibiotic that has activity against P. aeruginosa, fluoroquinolone resistance has increased as many as three fold since the last decade. Infections caused by P. aeruginosa that are fluoroquinolone resistant and positive for ExoU gene show worse clinical outcome. The aim of this study was to determine the positivity of ExoU gene TTSS and fluoroquinolone resistance of P. aeruginosa that isolated from sputum of nosocomial pneumonia patients in Sanglah Hospital, Bali. P. aeruginosa isolated from sputum of patient that diagnosed as nosocomial pneumonia, isolates had been identified phenotypically by Vitek2 Compact system (bioMérieux, Inc., Marcy-l'Etoile - France), and then continued by genotypic detection by PCR. The susceptibility testing of P. aeruginosa isolates to Ciprofloxacin were conducted by Vitek2 Compact, whereas ExoU genes were detected by PCR. Fifty-three P. aeruginosa isolates were identified in this study, in which 35 isolates (66.1%) had ExoU gene and 22 isolates (41.5%) were resistant to Ciprofloxacin. Based on nosocomial pneumonia type, the highest proportion of isolates genotipically ExoU+ and phenotypically Ciprofloxacin were on VAP group accounted for 57.1% and 54.5%, respectively. Chi-square analysis showed significant correlation between Ciprofloxacin resistance and ExoU gene (p=0.001). As a conclusion, the positivity of ExoU+ isolates were more likely found in Ciprofloxacin resistant group.

Kata kunci

Jaringan kolaborasi para penulis

31 penulis · 93 tautan kepenulisan bersama · 18 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Udayana University
  • Universitas Syiah Kuala
  • Mulawarman University
  • Sam Ratulangi University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Kuntaman KuntamanUniversitas Airlangga3
Manik Retno WahyunitisariUniversitas Airlangga2
Usman HadiUniversitas Airlangga2
Bagus SoebadiUniversitas Airlangga1
Diah Savitri ErnawatiUniversitas Airlangga1
Priyo HadiUniversitas Airlangga1
Reiska Kumala BaktiUniversitas Airlangga1
Dian RachmawatiMulawarman University1
Atika AtikaUniversitas Airlangga1
Wiwin RetnowatiUniversitas Airlangga1
Marijam PurwantaUniversitas Airlangga1
Nurul WiqoyahUniversitas Airlangga1
Sekar MaharaniUniversitas Airlangga1
Wilda MahdaniUniversitas Syiah Kuala1
Juliette A SeveriinAfiliasi tidak diketahui1
Wil H. F. GoessensAfiliasi tidak diketahui1
N den ToomAfiliasi tidak diketahui1
MarijamAfiliasi tidak diketahui1
Henri Alexander VerbrughAfiliasi tidak diketahui1
Anak Agung Ngurah Jaya KusumaUdayana University1
Arresta Vitasatria SuastikaUdayana University1
I Gde Raka WidianaUdayana University1
Ketut SuastikaUdayana University1
I Nengah SujayaUdayana University1
Mulyadi MulyadiSam Ratulangi University1
Soetjipto SoetjiptoUniversitas Airlangga1
Budi YantiUniversitas Syiah Kuala1
Muhammad AminUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Positivity of ExoU Gene of Type III Secretion System and Fluoroquinolone Resistance of Psedomonas aeruginosa from Sputum of Nosocomial Pneumonia Patients in Sanglah Hospital, Bali</dc:title><dc:creator>I Wayan Agus Gede Manik Saputra</dc:creator><dc:creator>Ni Made Mertaniasih</dc:creator><dc:creator>Ni Nengah Dwi Fatmawati</dc:creator><dc:subject>Pseudomonas aeruginosa</dc:subject><dc:subject>type III secretion system</dc:subject><dc:subject>fluoroquinolone resistance</dc:subject><dc:subject>ciprofloxacin resistance</dc:subject><dc:subject>nosocomial pneumonia</dc:subject><dc:subject>ventilator-associated pneumonia</dc:subject><dc:subject>virulence factors</dc:subject><dc:subject>sputum isolates</dc:subject><dc:subject>nosocomial infections</dc:subject><dc:description xml:lang="en">Pseudomonas aeruginosa is one of the Gram-negative rods bacteria that frequently cause nosocomial pneumonia. One of the main virulent effector proteins on Type III secretion system (TTSS) of P. aeruginosa is Exoenzyme U ( ExoU). ExoU works as a phospholipase A2 activity and exhibits lung tissue injury effect in pneumonia. As an antibiotic that has activity against P. aeruginosa, fluoroquinolone resistance has increased as many as three fold since the last decade. Infections caused by P. aeruginosa that are fluoroquinolone resistant and positive for ExoU gene show worse clinical outcome. The aim of this study was to determine the positivity of ExoU gene TTSS and fluoroquinolone resistance of P. aeruginosa that isolated from sputum of nosocomial pneumonia patients in Sanglah Hospital, Bali. P. aeruginosa isolated from sputum of patient that diagnosed as nosocomial pneumonia, isolates had been identified phenotypically by Vitek2 Compact system (bioMérieux, Inc., Marcy-l'Etoile - France), and then continued by genotypic detection by PCR. The susceptibility testing of P. aeruginosa isolates to Ciprofloxacin were conducted by Vitek2 Compact, whereas ExoU genes were detected by PCR. Fifty-three P. aeruginosa isolates were identified in this study, in which 35 isolates (66.1%) had ExoU gene and 22 isolates (41.5%) were resistant to Ciprofloxacin. Based on nosocomial pneumonia type, the highest proportion of isolates genotipically ExoU+ and phenotypically Ciprofloxacin were on VAP group accounted for 57.1% and 54.5%, respectively. Chi-square analysis showed significant correlation between Ciprofloxacin resistance and ExoU gene (p=0.001). As a conclusion, the positivity of ExoU+ isolates were more likely found in Ciprofloxacin resistant group.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2018-07-05</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v54i2.8863</dc:identifier><dc:identifier>10.20473/fmi.v54i2.8863</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 54 No 2 (2018); 129-129</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/8863/5076</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>